“sr-one” Archives

Entry Author Date Location
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
RaNA Therapeutics Receives $55,000,000 Series B Funding Round 07/23/15 Boston
Corporate VCs Still Out to Prove They Belong At the Deal Table 06/30/15 New York
With $30M, Spero Broadens Fight Against Drug-Resistant Bugs 06/08/15 Boston
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
ZappRx Nabs $5.6M, Inks Zafgen Deal to E-Prescribe Obesity Meds 04/02/15 Boston
With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test 03/18/15 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships 09/10/14 Raleigh Durham
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Boston VC Firms, Pharmas Team up on $23.5M Series A For Navitor 06/19/14 Boston
With $22M, True North Points Toward Rare-Disease Clinical Trials 06/17/14 San Francisco
Seeking Tau: BMS Buys iPierian and Brain-Disease Program for $175M 04/29/14 San Francisco
Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs 04/09/14 Boston
San Diego’s RuiYi Raises $15M for Pipeline of Biologic Therapeutics 03/28/14 San Diego
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
ZappRx Gets $1M From Atlas, SR One to E-Prescribe Specialty Meds 01/30/14 Boston
ZappRx Obtains $1,000,000 Seed Round 01/30/14 Boston
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday 01/29/14 Boston
Early Bird Ends Soon for Feb. 21 Healthcare Summit: Get Your Invite 01/23/14 Texas
Dicerna Joins Biotech IPO Queue, Plans $69M Raise 01/02/14 Boston
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
Aileron Therapeutics Garners $30,000,000 Series E Funding Round 11/18/13 Boston
iPierian Nabs $30M To Keep Alzheimer’s, Autoimmune Drugs Moving 09/04/13 San Francisco
iPierian Receives $30,000,000 New Funding Round 09/04/13 San Francisco
True North Therapeutics Garners Series A Funding 09/04/13 San Francisco
Page 1 of 5 next page »